Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety and efficacy of tocilizumab in German patients with polyarticular-course juvenile idiopathic arthritis (extension of WA19977)
2011-001097-25Phase 3Completed
- Sponsor
- Roche
- Start
- Sep 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of tocilizumab in juvenile idiopathic arthritis (JIA), sponsored by Roche. Started Sep 2011; status: completed.
02
Drugs
tocilizumab
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on 2011-001097-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001097-25.